The biotech industry in India which has been showing respectable growth for the past few years is projected to see a CAGR growth of around 20% between FY2011 & FY2013, says RNCOS in its latest research report “ Booming Biotech Market in India”. With so much of realized potential in the biotech industry, it is expected that Karnataka will emerge as a premium destination for investments by both the existing as well as the new players. We have found that there are many factors that make Karnataka an ideal platform for expansion and strategic growth of the biotech companies in the nation. Various drivers such as strong base of human resources, abundance of financing options like venture capitalists, and strong physical infrastructure will make Karnataka a preferred destination for the evolution of biotech industry in India.
Our research indicates that this Indian state has also kept its concern towards R&D expenditure and tax rebates and incentives. Furthermore, the government’s initiatives in facilitating implementation of the public-private partnerships in the region will further spur the optimistic performance of the industry.
Besides this, we have done extensive research and prudent analysis of the biotech industry in India. We have identified that the main reason that drives the growth of the biotech market in India is the cutting-edge research in genetic engineering, immunological techniques, cell culture methods, stem cells and hybridoma technology. Additionally, a well-established pharmaceutical industry of the country will also lead to a slew of innovative products in the country in the coming years. We have also evaluated various factors that will propel the growth of biotech market in India over the forecast period (FY 2011-FY 2013). The report also gives insight into the investment opportunities present in various regions of the country along with the role of the domestic as well as multinational companies that would stimulate the rapid growth of the Indian biotech market.
Our report “Booming Biotech Market in India” provides thorough analysis of the various segments of the biotech industry like biopharma, bioservices, bioagriculture, industrial biotechnology and bioinformatics. The report has thoroughly examined current market trends, industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Due consideration has been given to the possible aftereffects of recession on the industry. It will help clients to have a proper insight into the current and future outlook of the biotech market in India.
For more information visit: http://www.rncos.com/Report/IM110.htm
|
